UNSPSC 51142318: Naltrexone methobromide

This classification denotes an opiate antagonist with the molecular formula C21H26NO4.Br, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier RFO6IL3D3M, chemically known as morphinanium, 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-17-methyl-6-oxo-, bromide, (5.alpha.)-, but more generally known as naltrexone methobromide, which bears US NIH Compound Identifier 5361917. European Medicines Agency schedules naltrexone methobromide or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09143MIG.

Most nations, for tariff purposes, schedule naltrexone methobromide under HS 29391900. SMILES: C[N+]1(CC[C@]23C4C5CCC(C4O[C@H]2C(=O)CC[C@]3([C@H]1C5)O)O)CC6CC6.[BR-].

UNSPSC 51142318 Naltrexone methobromide is a Commodity code that designates pharmaceutical products used in opioid-use disorder treatment and overdose response. State and local governments procure this substance primarily through public health departments and county health authorities to support community health and overdose-prevention initiatives. The substance appears in solicitations alongside complementary products such as naloxone and drug deactivation systems, reflecting its role in integrated harm-reduction and emergency-response programs. Issuing bodies include county health departments and regional public health agencies managing substance-abuse response infrastructure.

Seminole County, Florida posted an IFB (Solicitation Number IFB60459723LAS) on June 30, 2026, requesting 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The solicitation required electronic bid submission, E-Verify compliance, drug-free workplace certification, and standard commercial insurance (workers' compensation, general liability, professional liability). The contract carried a two-year initial term with a one-year renewal option and a three-month probationary termination clause. While the source does not identify additional recent opportunities under this specific Commodity code, the Seminole County procurement signals continued public-health demand for overdose-response pharmaceuticals in Florida and suggests that state and local procurement under this code focuses on recurring annual buys with fixed volumes and quarterly delivery schedules.